Trial Profile
Nasonex Nasal Suspension 50 microg Long-Term Designated Drug Use Investigation.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Feb 2022
Price :
$35
*
At a glance
- Drugs Mometasone (Primary)
- Indications Perennial allergic rhinitis; Seasonal allergic rhinitis
- Focus Adverse reactions
- Sponsors Organon
- 04 Sep 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Oct 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 09 Oct 2012 Additional lead trial centre deleted as reported by ClinicalTrials.gov record.